Takeda Pharmaceutical
TAK
#452
Rank
$53.77 B
Marketcap
$16.16
Share price
-1.04%
Change (1 day)
26.25%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Takeda Pharmaceutical CIK: 0001395064
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Takeda Pharmaceutical only files 20-F reports

Thumbnail Takeda Pharmaceutical 20-F Annual Report 2025

20-F Annual Report 2025

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)